ScholarLens Back to search
2013•Laboratory Medicine and ClinicRequires access

The analysis on serum levels of carbohydrate antigens in patients with lung cancer,breast cancer and pancreatic cancer

Xue-dong Lu

Open publisher page 0 citations

Abstract

Objective To observe diagnosis values of CA125,CA199,CA153 of plasma in patients with lung cancer,breast cancer and pancreatic cancer during treatments.Methods Levels of CA125,CA199,CA153 of healthy group and patients with the clinically diagnosed lung cancer,breast cancer and pancreatic cancer were assessed by CLIA system.Results In comparison with the control group,the level of CA153 was higher in patients with lung cancer(t=2.222 1,P0.05);the levels of CA125,CA199,CA153 were higher in patients with breast cancer(t=2.184 8,t=2.512 3,t=2.153 3,P0.05).In addition,the levels of CA125,CA199 were higher in patients with pancreatic cancer(t=2.881 4,P0.01 or t=12.540 8,P0.01).And the positive rate of CA199 reached 100% in patients with pancreatic.Conclusion The test results of CA125,CA199,CA153 have important reference values in patients with lung cancer,breast cancer and pancreatic cancer during treatment.

About this research paper

What this paper is about

Objective To observe diagnosis values of CA125,CA199,CA153 of plasma in patients with lung cancer,breast cancer and pancreatic cancer during treatments.Methods Levels of CA125,CA199,CA153 of healthy group and patients with the clinically diagnosed lung cancer,breast cancer and pancreatic cancer were assessed by CLIA system.Results In comparison with the control group,the level of CA153 was higher in patients with lung cancer(t=2.222 1,P0.05);the levels of CA125,CA199,CA153 were higher in patients with breast cancer(t=2.184 8,t=2.512 3,t=2.153 3,P0.05).In addition,the levels of CA125,CA199 were higher in patients with pancreatic cancer(t=2.881 4,P0.01 or t=12.540 8,P0.01).And the positive rate of CA199 reached 100% in patients with pancreatic.Conclusion The test results of CA125,CA199,CA153 have important reference values in patients with lung cancer,breast cancer and pancreatic cancer during treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe diagnosis values of CA125,CA199,CA153 of plasma in patients with lung cancer,breast cancer and pancreatic cancer during treatments.Methods Levels of CA125,CA199,CA153 of healthy group and patients with the clinically diagnosed lung cancer,breast cancer and pancreatic cancer were assessed by CLIA system.Results In comparison with the control group,the level of CA153 was higher in patients with lung cancer(t=2.222 1,P0.05);the levels of CA125,CA199,CA153 were higher in patients with breast cancer(t=2.184 8,t=2.512 3,t=2.153 3,P0.05).In addition,the levels of CA125,CA199 were higher in patients with pancreatic cancer(t=2.881 4,P0.01 or t=12.540 8,P0.01).And the positive rate of CA199 reached 100% in patients with pancreatic.Conclusion The test results of CA125,CA199,CA153 have important reference values in patients with lung cancer,breast cancer and pancreatic cancer during treatment.

Key concepts: Medicine, Pancreatic cancer, Breast cancer, Lung cancer, Internal medicine, Cancer, Oncology, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The analysis on serum levels of carbohydrate antigens in patients with lung cancer,breast cancer and pancreatic cancer — Research Paper | ScholarLens